Cargando…
3D Tissue-Engineered Vascular Drug Screening Platforms: Promise and Considerations
Despite the efforts devoted to drug discovery and development, the number of new drug approvals have been decreasing. Specifically, cardiovascular developments have been showing amongst the lowest levels of approvals. In addition, concerns over the adverse effects of drugs to the cardiovascular syst...
Autores principales: | Marei, Isra, Abu Samaan, Tala, Al-Quradaghi, Maryam Ali, Farah, Asmaa A., Mahmud, Shamin Hayat, Ding, Hong, Triggle, Chris R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931492/ https://www.ncbi.nlm.nih.gov/pubmed/35310996 http://dx.doi.org/10.3389/fcvm.2022.847554 |
Ejemplares similares
-
Biofunctionalization of cardiovascular stents to induce endothelialization: Implications for in- stent thrombosis in diabetes
por: Marei, Isra, et al.
Publicado: (2022) -
Repurposing Metformin for Vascular Disease
por: Triggle, Chris R., et al.
Publicado: (2023) -
Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1
por: Arunachalam, Gnanapragasam, et al.
Publicado: (2014) -
Enhancing NAD(+) Metabolome in Cardiovascular Diseases: Promises and Considerations
por: Jahan, Fahmida, et al.
Publicado: (2021) -
Engineering Myocardium for Heart Regeneration—Advancements, Considerations, and Future Directions
por: Jarrell, Dillon K., et al.
Publicado: (2020)